Skip to main content
. 2023 Jun 30;17:1118253. doi: 10.3389/fnins.2023.1118253

TABLE 2.

Artificial neural network evaluation of the impact of virtual lisdexamfetamine over comorbidities.

Depression Anxiety Bipolar disorder Binge eating disorder Tic disorder
vLDX Very high (94%) Medium (76%) Low (17%) Very high (94%) Medium (71%)

Categories: very high (score [100–92], p-value < 0.01); high (score [92–77], p-value < 0.05); medium (score [77–37], p-value < 0.25); low (score < 37, p-value ≥ 0.25). vLDX, virtual lisdexamfetamine.